*** This version of Confluence is for testing only and contains a copy of content from June 29th 2026. No changes will be preserved. ***
| Craig A. Wheeler |
Momenta Pharmaceuticals, |
Inc. |
Craig A. Wheeler joined Momenta Pharmaceuticals, Inc. as Chief Executive Officer as CEO in September of 2006. He also serves as a member of the company’s board of directors. Momenta Pharmaceuticals is a biotechnology company specializing in the detailed characterization and engineering of complex drugs. In July 2010 Momenta and its collaboration partner Sandoz received FDA approval for the first ever generic Lovenox. In May 2012, The led the
com¬pany through the launch of its first complex drug products, including
the first generic versions of LOVENOX® and COPAXONE®. In 2011,
he was an E&Y Entrepreneur of the Year Regional Award winner. In May
2012, the Boston Globe named Momenta the number one company in their
annual Globe 100 survey of top performing companies. Craig also serves as the Board Chairman for The Generic Pharmaceutical Association (GPhA) for which he was elected in February of 2014. Prior to joining
Momenta, Craig worked at Chiron Corporation as President, Chiron BioPharmaceuticals, which had products treating cancer, cystic fibrosis, and multiple sclerosis. Prior to joining Chiron, Craig Wheeler was president of Chiron BioPharmaceuticals where
during his five-year tenure the pharmaceutical division’s global sales
more than doubled. Before that, he was a senior member of The Boston
Consulting Group’s health care practice. Craig also served as the Chairman of the Board of Avanir Pharmaceuticals from May 2007 until it was acquired in January 2015 by Otsuka Pharmaceuticals for $3.5 billion. He holds a B.S. and an M.S. degree in chemical engineering from Cornell University, and an MBA from the Wharton School of the University of Pennsylvania.
He began his career at Merck’s
MSDRL research unit. Wheeler is currently a member of the board of directors
of Amicus Therapeutics. He also previously served on the board of
the Association for Accessible Medicines as well as being chairman of the
board of Avanir Pharmaceuticals.
301 Binney 675 West Kendall Street
Cambridge, MA 02142
617 395-5158
Craig_wheeler@comcast.net